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We present a 70-year-old, Caucasian, HIV-negative
patient, from a rural district in the Western Cape, South
Africa. She presented to an outreach clinic with a 10-year
history of left knee pain. Clinically she had a 20 degrees
valgus deformity (correctable) without fixed flexion.
Radiographically there was marked osteopaenia, cysts
and degenerative changes. A clinico-radiological
diagnosis of rheumatoid arthritis was made (Figures 1 
and 2). She had no previous medical history of note, and
did not have any infiltrations or penetrating wounds of
that knee. No other joints were affected.
A total knee replacement was performed in April 2013
(Triathlon®, Stryker). The pre-operative blood investiga-
tions included a white cell count of 7.10 × 109 and
rheumatoid factor of 198.3 IU/ml. The erythrocyte
sedimentation rate was not requested. 
Intra-operative findings included large cysts in the
medial tibial plateau, medial femoral condyle and a large
concavity of the lateral plateau requiring bone graft, as
well as marked distal femoral erosion with minimal
erosion of the posterior aspect of the lateral femoral
condyle. This atypical pattern of joint erosion prompted us
to sample synovial tissue.
Introduction
Infection of prosthetic joints with non-tuberculous mycobacteria (NTM) is rare. The rapidly growing mycobac-
teria (RGM) are a subgroup of NTM. They are not very virulent organisms, found ubiquitously in the
environment, and most infections in humans are due to direct inoculation of the organism into a joint or soft
tissue. We describe a 70-year-old patient, who developed an infection with Mycobacterium fortuitum after primary
knee arthroplasty, one of only a handful described in the literature. Peri-prosthetic infections with RGM are a
challenge because there is a lack of data guiding management, and because the diagnosis is often delayed.
Routine cultures of joint effusions or tissue are often discarded before the non-tuberculous mycobacteria have a
chance to culture (in our case, 14 days). Principles of treatment include: making a diagnosis from tissue culture,
staged revision surgery with aggressive surgical debridement of the joint and high dosages antibiotics (for at least
six weeks, treating empirically initially until a sensitivity profile for the organism is available). The second stage
of the revision should be delayed by 3–6 months. In our case the removed implant was autoclaved and re-
implanted loosely with antibiotic-loaded cement as part of the first-stage revision.
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Post-operatively she did very well, her early recovery and
rehabilitation was uneventful, and she was discharged a
week later in good health. The post-operative blood investi-
gations also suggested a diagnosis of rheumatoid arthritis.
Anti-cyclic citrullinated peptide: more than 250 units,
erythrocyte sedimentation rate: 85 mm/hr.
Histological investigation of the synovial biopsy showed
proliferated synovial cell lining, infiltration of lymphocytes,
plasma cells, but also neutrophils. The histology was
therefore highly suggestive of rheumatoid arthritis, but the
component of acute inflammation was unaccounted for. No
microbiological examinations were ordered at the time.
Figures 3 and 4 show component placement post-operatively.
Intra-operative findings included large cysts in the 
medial tibial plateau, medial femoral condyle and a large 
concavity of the lateral plateau requiring bone graft, as well 
as marked distal femoral erosion with minimal erosion of the
posterior aspect of the lateral femoral condyle
Figure 1. AP radiograph, pre-operative Figure 2. Lateral radiograph, pre-operative
Figure 3. AP radiograph, before revision Figure 4. Lateral radiograph before revision
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Three weeks post-operatively she presented to her local
district hospital with symptoms of knee pain and swelling,
vomiting and dysuria. She was diagnosed with acute
gastroenteritis and a urinary tract infection. However, her
left knee pain and swelling was not addressed at the time. 
The patient became lost to arthroplasty follow-up and
visits the clinic for the first time 2 months after the surgery.
At this stage her knee was painful, tender and warm, and
had developed two draining sinuses. The inflammatory
markers were raised. White cell count: 10.8 × 109, erythrocyte
sedimentation rate: 100 mm/hr, C-reactive protein: 
82.3 mg/L.
She underwent debridement of the knee as an
emergency and tissue samples were taken for diagnostic
purposes. Intravenous ampicillin, 2 g, 6 hrly and
cloxacillin 2 g, 6 hrly, was started empirically. Routine
cultures were negative; however, TB investigations were
also ordered, and although direct microscopy was
negative, the cultures revealed acid-fast bacilli at day
five and day 12, respectively, but polymerase chain
reaction test for MTB complex was negative. The
organism was later identified as Mycobacterium fortuitum.
Histological examination revealed features of acute and
chronic inflammation, with granulation tissue, hemosidero-
phages, fibrosis and giant cell formation.
We decided on empiric therapy of the rapidly growing
mycobacteria based on available literature:1 meropenem, 
1 g, 8 hrly, IV and ciprofloxacin, 750 mg 12 hrly, PO.
Her second debridement took place three weeks after the
first debridement. The implants and cement were removed
completely. A radical synovectomy was performed. The
removed femoral and tibial implants were cleaned and
sterilised in an autoclave. The sterilised components were
loosely re-implanted as a spacer with cement loaded with 
5 g of vancomycin and 3.6 g of tobramycin per 40 g of
Simplex Cement. A conventional UHMWPE spacer was also
inserted.
Response to therapy was excellent – reduced pain and
swelling and active flexion to 90° early post-operatively. The
infection markers returned to almost normal levels within
three weeks. White cell count: 7.0 × 109, erythrocyte
sedimentation rate: 46 mm in 1hr and C-reactive protein:
11.8 mg/L.
The patient remained in hospital for four weeks, receiving
meropenem intravenously. The ciprofloxacin was stopped a
week after the debridement, and replaced with amikacin,
600 mg dly and cefuroxime, 1.5 g, 6 hrly. At the end of four
weeks of total intravenous therapy she was discharged
home with a course of ciprofloxacin (500 mg, 12 hrly, orally)
and cotrimoxazole (160/800 mg, 12 hrly, orally) for six
weeks. The second stage revision of the joint three months
after completion of the antibiotic course was planned if she
remained clinically aseptic.
At the most recent follow-up visit in January 2014 
(9 months after the primary total knee replacement) she
was very satisfied with regard to function and pain. She
had a full range of motion of the left knee, was fully
weightbearing and all the inflammatory markers were
within normal limits. She refused the second stage of
revision. Figures 5 and 6 show the left knee at last follow-
up visit.
Literature review
A literature search revealed 22 previous cases of prosthetic
knee joint infections with rapidly growing mycobacteria
(RGM).2–15
Infections of other prosthetic joints and infections where
the infectious agent was one of the other non-tuberculous
mycobacteria (NTM) were not included. 
The most prevalent organisms were M. fortuitum
(11 patients), M. chelonae (four patients), and M. goodii
(three patients). By far the most were immunocompetent
and not receiving any immunosuppressive medication.
The average time to onset of symptoms from prosthesis
implantation was 136.6 weeks, in the 20 patients of whom
this information was stated in the case reports. The
shortest was 1 week,2 and the longest was 16 years.10
At presentation the mean erythrocyte sedimentation rate
(ESR) was 38.2 mm/hr (reported in eight patients), the
highest measured was 96 mm/hr.3 The time for RGM to
appear in culture was reported in seven patients and the
average time was 6.8 days. The longest was 11 days.13
Figures 5 and 6. The left knee at last follow-up.
Response to therapy was excellent – reduced pain and swelling 
and active flexion to 90° early post-operatively
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In most cases the patients received at least one
debridement in theatre with removal of the implants and
insertion of an antibiotic-loaded cement spacer. The average
time to successful revision arthroplasty, from the removal of
the implant, was 21.5 weeks (reported in 12 cases). The
shortest time to successful re-implantation was 12 weeks.9
One case of relapse was reported in 1987, after the revision
arthroplasty was performed only seven weeks after
resection arthroplasty. The infection was treated with
doxycycline as suppressive therapy, until a superinfection
with yet another organism prompted resection and
arthrodesis.6
In four cases, for various reasons, the prosthesis was
retained and the infection controlled with long-term
suppressive therapy. 2,10,15
Table I summarises the sensitivity profiles for the reported
cases.
Discussion
Infection of a prosthetic joint can be a potentially devastating
complication following knee arthroplasty and a critical part
of treatment is identification of the causative organism, the
most common being Staphylococcus.16
Infections with RGM can be difficult to diagnose for a
variety of reasons. They are rarely the causative organism
and therefore not suspected. Acid-fast staining is often not
positive and although quicker than M. tuberculosis, they take
longer to culture than other organisms (1–2 weeks in liquid
cultures),17 and by that time routine cultures might have
been discarded.
The RGM are divided into three groups, based on differ-
entiation according to antimicrobial susceptibility testing:
fortuitum group, with wider antimicrobial sensitivity,
chelonae/abcessus group and smegmatis group that incor-
porates M. goodii and M. woliskyi.18
These organisms are pervasive in the environment and
have been isolated from water, soil, and in hospitals.19
Infections in humans have been well described, and occur
mostly secondary to direct inoculation20 or contaminations of
wounds. In case reports these often occurred in clusters, and
on more than one occasion contaminated hospital fresh
water supply was suspected.21,22
Cornelius et al. described a cluster of three M. fortuitum
prosthetic joint infections (two knees and one hip), postu-
lating intra-operative contamination.9 Ahmad describes a
case of peri-prosthetic infection, most probably acquired
during physical therapy in a whirlpool bath.12 However, in
most cases of peri-prosthetic infection with NTM the source
of infection is never identified. 
Predisposing factors have been proposed, like rheumatoid
arthritis, other comorbidities and pre-operative intra-
articular steroid depot injections.3 Whether this implies a
possible direct inoculation of the organisms into the joint or
the immune depressing effects of the steroid is unclear.
Furthermore, NTM infection of native joints, even one
without violation of the joint (in an HIV-positive patient),
has been described, implying that purely haematogenous
spread also occurs.23,24
Infections with RGM can be difficult to diagnose
MIC, µg/mL
Patient Organism AMK TOB CFX CLR DOX TMP-SMX CIP MOX IMP LNZ
1 M. fortuitum 2 (S) 16 (R) 0.25 0.12 4 32 (R)
23 M. fortuitum 1 >128 (R) 0.5 0.5 >4 (R) >16
M. abcessus 0.5 >128 (R) >8 >16 0.25
311 M. fortuitum (S) (R) (S) (S)
45 M. fortuitum <0.5 32 (R) <0.25 <0.25 >8/125 (R) 2 4
52 M. chelonae 32 (I) 16 (R) >16 (R) 0.5 >128 (R) >2/38 (R) >2 (R) 16 (R)
62 M. chelonae 32 (I) >16 (R) 16 (S) >128 (R) .../>64 (R) >16 (R) 8
72 M. smegatis <2 <1 128 (R) >32 (R) <0.12 …/8 0.5 <0.12 2 <2
82 M. fortuitum <2 16 (R) 32 (I) 2 >64 (R) …/<4 <0.25 <0.12 1 <2
92 M. fortuitum <2 16 (R) 64 (I) 4 (I) >64 (R) …/8 <.25 0.5 4 8
102 M. chelonae 8 <1 256 (R) <0.25 (S) <0.25 …/32 (S) 2 (I) 4 32 (R) <2 (S)
112 M. abcessus 8 8 (I) 32 (I) <0.25 (S) >64 (R) …/>64 (R) >16 (R) 4 (S) 16 (I)
1214 M. woliskyi 16(S) >256 (R) 64 (R) 0.5 (S) 1 (S) <0.125 (S) >64 (R)
1312 M. goodii (S) (S) (S) (S) (S) (S)
1411 M. fortuitum (S) (R) (S) (S) (R) (S) (S)
1513 M. goodii <0.5 (S) 4 (S) 0.25 (S)
168 M. chelonae (S) (S) (S) (S)
177 M. fortuitum (S)
NOTE: AMK, amikacin; CFX, cefoxitin; CIP, ciprofloxacin; CLR, clarithromycin; DOX, doxycycline; IMP, imipenem; LNZ, lenezolid; MOX, moxifloxacin; (I), intermediate;
(S), sensitive; (R) resistant.
Table I: Sensitivity profiles of organisms at initial culture
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This family of organisms grow in biofilm,25 possibly
explaining why there is a delay in presentation, but more
importantly, explaining why aggressive debridement,
removal of the implants, and prolonged courses of antibi-
otics seem to offer the only hope of cure.
Conclusion
Prosthetic joint infection with non-tuberculous mycobacteria
can be considered as rare. We report a case of a prosthetic
knee infection with one of the rapidly growing mycobac-
teria, M. fortuitum and review the previous case reports in
the literature. Considering the outcomes of previously
reported cases, delay in identification of the causative
organism appears to be a significant cause of morbidity,
emphasising the importance of a high index of suspicion,
especially if initial microbial cultures are negative.
The most effective way to treat these infections seems to be
removal of the implant and debridement combined with
antimicrobial therapy for at least six months, guided by
sensitivity testing, before re-implantation is attempted.
Based on documented sensitivity profiles of previous cases,
we recommend empiric meropenem, IV and ciprofloxacin,
IV while sensitivity profiles are pending, and the use of
antibiotic-impregnated cement.
For patients that are poor candidates for surgery, however,
chronic suppressive therapy in a poor surgical candidates
has also been shown to be effective.2,10,15
The content of this article is the original work of the author. No
benefits of any form have been or are to be received from a
commercial party related directly or indirectly from this article.
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